Roche lifts 2019 outlook after first-quarter sales beatSwiss drugmaker Roche raised its 2019 outlook after first-quarter sales rose 8 percent, beating analyst estimates on the strength of newer medicines including multiple sclerosis treatment Ocrevus and cancer immunotherapy Tece…Read More
Asia comforted as China data hint at recoveryAsian share markets pulled ahead on Wednesday as investors were relieved after a raft of Chinese data beat expectations in a sign Beijing's policy stimulus may finally be gaining traction in the world's second-largest economy…Read More
0 comments:
Post a Comment